Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Food-Grade Nanovehicles for Hydrophobic Nutraceuticals or Bioactives

被引:23
|
作者
Tang, Chuan-He [1 ,2 ]
Chen, Huan-Le [1 ]
Dong, Jin-Ru [3 ]
机构
[1] South China Univ Technol, Sch Food Sci & Engn, Res Grp Food Colloids & Nanotechnol, Guangzhou 510641, Peoples R China
[2] Chengdu Univ, Key Lab Meat Proc Sichuan, Chengdu 610106, Peoples R China
[3] Ocean Univ China, Coll Food Sci & Engn, Qingdao 266100, Peoples R China
来源
APPLIED SCIENCES-BASEL | 2023年 / 13卷 / 03期
基金
中国国家自然科学基金;
关键词
solid lipid nanoparticles (SLNs); nanostructured lipid carriers (NLCs); nanovehicle; nutraceuticals; stability; bioavailability; IMPROVING ORAL BIOAVAILABILITY; IN-VITRO; BETA-CAROTENE; PHYSICOCHEMICAL CHARACTERIZATION; NANODELIVERY SYSTEMS; DRUG-DELIVERY; GASTROINTESTINAL STABILITY; ANTIMICROBIAL ACTIVITY; INTESTINAL-ABSORPTION; CELLULAR UPTAKE;
D O I
10.3390/app13031726
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Although solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have been successfully used as drug delivery systems for about 30 years, the usage of these nanoparticles as food-grade nanovehicles for nutraceuticals or bioactive compounds has been, relatively speaking, scarcely investigated. With fast-increasing interest in the incorporation of a wide range of bioactives in food formulations, as well as health awareness of consumers, there has been a renewed urge for the development of food-compatible SLNs and/or NLCs as nanovehicles for improving water dispersibility, stability, bioavailability, and bioactivities of many lipophilic nutraceuticals or poorly soluble bioactives. In this review, the development of food-grade SLNs and NLCs, as well as their utilization as nanosized delivery systems for lipophilic or hydrophobic nutraceuticals, was comprehensively reviewed. First, the structural composition and preparation methods of food-grade SLNs and NLCs were simply summarized. Next, some key issues about the usage of such nanoparticles as oral nanovehicles, e.g., incorporation and release of bioactives, oxidative stability, lipid digestion and absorption, and intestinal transport, were critically discussed. Then, recent advances in the utilization of SLNs and NLCs as nanovehicles for encapsulation and delivery of different liposoluble or poorly soluble nutraceuticals or bioactives were comprehensively reviewed. The performance of such nanoparticles as nanovehicles for improving stability, bioavailability, and bioactivities of curcuminoids (and curcumin in particular) was also highlighted. Lastly, some strategies to improve the oral bioavailability and delivery of loaded nutraceuticals in such nanoparticles were presented. The review will be relevant, providing state-of-the-art knowledge about the development of food-grade lipid-based nanovehicles for improving the stability and bioavailability of many nutraceuticals.
引用
收藏
页数:51
相关论文
共 50 条
  • [1] Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery
    Goo Yoon
    Jin Woo Park
    In-Soo Yoon
    [J]. Journal of Pharmaceutical Investigation, 2013, 43 (5) : 353 - 362
  • [2] Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam
    Khalil, Rawia M.
    Abd-Elbary, A.
    Kassem, Mahfoz A.
    Ghorab, Mamdouh M.
    Basha, Mona
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2014, 19 (03) : 304 - 314
  • [3] Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors
    Mehrdadi, Soheil
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (03) : 512 - 520
  • [4] Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das, Surajit
    Ng, Wai Kiong
    Tan, Reginald B. H.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 47 (01) : 139 - 151
  • [5] Solid lipid nanoparticles (SLNs): delivery vehicles for food bioactives
    Aditya, N. P.
    Ko, Sanghoon
    [J]. RSC ADVANCES, 2015, 5 (39) : 30902 - 30911
  • [6] Preparation, characterization and in vivo pharmacokinetic evaluation of curcuminoids-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs)
    Dolatabadi, Shabnam
    Karimi, Maryam
    Nasirizadeh, Samira
    Hatamipour, Mahdi
    Golmohammadzadeh, Shiva
    Jaafari, Mahmoud Reza
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 62
  • [7] Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration
    Song, Aihua
    Zhang, Xiaoshu
    Li, Yanting
    Mao, Xinjuan
    Han, Fei
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (08) : 1308 - 1314
  • [8] Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
    Mura, Paola
    Maestrelli, Francesca
    D'Ambrosio, Mario
    Luceri, Cristina
    Cirri, Marzia
    [J]. PHARMACEUTICS, 2021, 13 (04)
  • [9] Developed and characterization of nanostructured lipid carriers containing food-grade interesterified lipid phase for food application
    da Silva, Mayanny Gomes
    de Godoi, Kamila Ramponi Rodrigues
    Gigante, Mirna Lucia
    Cardoso, Lisandro Pavie
    Ribeiro, Ana Paula Badan
    [J]. FOOD RESEARCH INTERNATIONAL, 2022, 155
  • [10] Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations
    Jansook, Phatsawee
    Fulop, Zoltan
    Ritthidej, Garnpimol C.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (04) : 560 - 567